APA (7th ed.) Citation

Sebastian, M., Schröder, A., Scheel, B., Hong, H. S., Muth, A., von Boehmer, L., . . . Gnad-Vogt, U. (2019). A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. Cancer Immunology, Immunotherapy, 68(5), 799. https://doi.org/10.1007/s00262-019-02315-x

Chicago Style (17th ed.) Citation

Sebastian, Martin, et al. "A Phase I/IIa Study of the MRNA-based Cancer Immunotherapy CV9201 in Patients with Stage IIIB/IV Non-small Cell Lung Cancer." Cancer Immunology, Immunotherapy 68, no. 5 (2019): 799. https://doi.org/10.1007/s00262-019-02315-x.

MLA (9th ed.) Citation

Sebastian, Martin, et al. "A Phase I/IIa Study of the MRNA-based Cancer Immunotherapy CV9201 in Patients with Stage IIIB/IV Non-small Cell Lung Cancer." Cancer Immunology, Immunotherapy, vol. 68, no. 5, 2019, p. 799, https://doi.org/10.1007/s00262-019-02315-x.